Skip to content

Melphalan

Melphalan (Alkeran) is an alkylating medicine used to treat multiple myeloma and ovarian carcinoma. This page covers the one product currently listed in the catalogue.

Alkeran

Multiple Myeloma, Ovarian Carcinoma

2mg

Melphalan tablets for multiple myeloma and ovarian carcinoma. As an alkylating agent, it damages the DNA of cancer cells to stop them dividing.

From$4.56/ tabletView

Key points

  • The only listed formulation is Alkeran 2mg tablet, supplied by GlaxoSmithKline as the originator brand for this ingredient.
  • Melphalan is an alkylating agent that damages the DNA of cancer cells, slowing or stopping their growth.
  • The medicine is categorised under Women’s Health and Oncology Support in this catalogue, reflecting its therapeutic use in cancer care.

What melphalan is used for

Melphalan is an alkylating agent used to treat Multiple Myeloma and Ovarian Carcinoma. The sole product in this listing is Alkeran 2mg tablet, supplied by GlaxoSmithKline as the originator brand and categorised under Women’s Health.

Further reading